<SEC-DOCUMENT>0001104659-25-053174.txt : 20250527
<SEC-HEADER>0001104659-25-053174.hdr.sgml : 20250527
<ACCEPTANCE-DATETIME>20250527205837
ACCESSION NUMBER:		0001104659-25-053174
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250527
DATE AS OF CHANGE:		20250527

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lantern Pharma Inc.
		CENTRAL INDEX KEY:			0001763950
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				463973463
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39318
		FILM NUMBER:		25990661

	BUSINESS ADDRESS:	
		STREET 1:		1920 MCKINNEY AVENUE
		STREET 2:		7TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		972-277-1136

	MAIL ADDRESS:	
		STREET 1:		1920 MCKINNEY AVENUE
		STREET 2:		7TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lantern Pharma
		DATE OF NAME CHANGE:	20190108

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOS Fund I QP, LP
		CENTRAL INDEX KEY:			0001700297
		ORGANIZATION NAME:           	
		EIN:				820592757
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		1401 FOCH STREET, SUITE 140
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76107
		BUSINESS PHONE:		817-984-5964

	MAIL ADDRESS:	
		STREET 1:		1401 FOCH STREET, SUITE 140
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76107
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: BIOS Fund I QP, LP -->
          <cik>0001700297</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001763950</issuerCik>
      <issuerName>Lantern Pharma Inc.</issuerName>
      <secFileNumber>001-39318</secFileNumber>
      <issuerAddress>
        <com:street1>1920 MCKINNEY AVENUE, 7TH FLOOR</com:street1>
        <com:city>DALLAS</com:city>
        <com:stateOrCountry>TX</com:stateOrCountry>
        <com:zipCode>75201</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972-277-1136</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Bios Fund I QP, LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate (10% owner)</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Sanders Morris Harris</name>
        <address>
          <com:street1>5950 Sherry Lane, Ste 470</com:street1>
          <com:city>Dallas</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>75225</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>29576</noOfUnitsSold>
      <aggregateMarketValue>97305.04</aggregateMarketValue>
      <noOfUnitsOutstanding>10784725</noOfUnitsOutstanding>
      <approxSaleDate>05/27/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>06/15/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Conversion of Shares in IPO</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>329903</amountOfSecuritiesAcquired>
      <paymentDate>06/15/2020</paymentDate>
      <natureOfPayment>Conversion</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>05/27/2025</noticeDate>
      <signature>/s/ John Fucci</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
